Cargando…

Curcumin–Coumarin Hybrid Analogues as Multitarget Agents in Neurodegenerative Disorders

Neurodegenerative diseases have a complex nature which highlights the need for multitarget ligands to address the complementary pathways involved in these diseases. Over the last decade, many innovative curcumin-based compounds have been designed and synthesized, searching for new derivatives having...

Descripción completa

Detalles Bibliográficos
Autores principales: Quezada, Elías, Rodríguez-Enríquez, Fernanda, Laguna, Reyes, Cutrín, Elena, Otero, Francisco, Uriarte, Eugenio, Viña, Dolores
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348017/
https://www.ncbi.nlm.nih.gov/pubmed/34361702
http://dx.doi.org/10.3390/molecules26154550
_version_ 1783735235060432896
author Quezada, Elías
Rodríguez-Enríquez, Fernanda
Laguna, Reyes
Cutrín, Elena
Otero, Francisco
Uriarte, Eugenio
Viña, Dolores
author_facet Quezada, Elías
Rodríguez-Enríquez, Fernanda
Laguna, Reyes
Cutrín, Elena
Otero, Francisco
Uriarte, Eugenio
Viña, Dolores
author_sort Quezada, Elías
collection PubMed
description Neurodegenerative diseases have a complex nature which highlights the need for multitarget ligands to address the complementary pathways involved in these diseases. Over the last decade, many innovative curcumin-based compounds have been designed and synthesized, searching for new derivatives having anti-amyloidogenic, inhibitory of tau formation, as well as anti-neuroinflammation, antioxidative, and AChE inhibitory activities. Regarding our experience studying 3-substituted coumarins with interesting properties for neurodegenerative diseases, our aim was to synthesize a new series of curcumin–coumarin hybrid analogues and evaluate their activity. Most of the 3-(7-phenyl-3,5-dioxohepta-1,6-dien-1-yl)coumarin derivatives 11–18 resulted in moderated inhibitors of hMAO isoforms and AChE and BuChE activity. Some of them are also capable of scavenger the free radical DPPH. Furthermore, compounds 14 and 16 showed neuroprotective activity against H(2)O(2) in SH-SY5Y cell line. Nanoparticles formulation of these derivatives improved this property increasing the neuroprotective activity to the nanomolar range. Results suggest that by modulating the substitution pattern on both coumarin moiety and phenyl ring, ChE and MAO-targeted derivatives or derivatives with activity in cell-based phenotypic assays can be obtained.
format Online
Article
Text
id pubmed-8348017
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83480172021-08-08 Curcumin–Coumarin Hybrid Analogues as Multitarget Agents in Neurodegenerative Disorders Quezada, Elías Rodríguez-Enríquez, Fernanda Laguna, Reyes Cutrín, Elena Otero, Francisco Uriarte, Eugenio Viña, Dolores Molecules Article Neurodegenerative diseases have a complex nature which highlights the need for multitarget ligands to address the complementary pathways involved in these diseases. Over the last decade, many innovative curcumin-based compounds have been designed and synthesized, searching for new derivatives having anti-amyloidogenic, inhibitory of tau formation, as well as anti-neuroinflammation, antioxidative, and AChE inhibitory activities. Regarding our experience studying 3-substituted coumarins with interesting properties for neurodegenerative diseases, our aim was to synthesize a new series of curcumin–coumarin hybrid analogues and evaluate their activity. Most of the 3-(7-phenyl-3,5-dioxohepta-1,6-dien-1-yl)coumarin derivatives 11–18 resulted in moderated inhibitors of hMAO isoforms and AChE and BuChE activity. Some of them are also capable of scavenger the free radical DPPH. Furthermore, compounds 14 and 16 showed neuroprotective activity against H(2)O(2) in SH-SY5Y cell line. Nanoparticles formulation of these derivatives improved this property increasing the neuroprotective activity to the nanomolar range. Results suggest that by modulating the substitution pattern on both coumarin moiety and phenyl ring, ChE and MAO-targeted derivatives or derivatives with activity in cell-based phenotypic assays can be obtained. MDPI 2021-07-28 /pmc/articles/PMC8348017/ /pubmed/34361702 http://dx.doi.org/10.3390/molecules26154550 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Quezada, Elías
Rodríguez-Enríquez, Fernanda
Laguna, Reyes
Cutrín, Elena
Otero, Francisco
Uriarte, Eugenio
Viña, Dolores
Curcumin–Coumarin Hybrid Analogues as Multitarget Agents in Neurodegenerative Disorders
title Curcumin–Coumarin Hybrid Analogues as Multitarget Agents in Neurodegenerative Disorders
title_full Curcumin–Coumarin Hybrid Analogues as Multitarget Agents in Neurodegenerative Disorders
title_fullStr Curcumin–Coumarin Hybrid Analogues as Multitarget Agents in Neurodegenerative Disorders
title_full_unstemmed Curcumin–Coumarin Hybrid Analogues as Multitarget Agents in Neurodegenerative Disorders
title_short Curcumin–Coumarin Hybrid Analogues as Multitarget Agents in Neurodegenerative Disorders
title_sort curcumin–coumarin hybrid analogues as multitarget agents in neurodegenerative disorders
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348017/
https://www.ncbi.nlm.nih.gov/pubmed/34361702
http://dx.doi.org/10.3390/molecules26154550
work_keys_str_mv AT quezadaelias curcumincoumarinhybridanaloguesasmultitargetagentsinneurodegenerativedisorders
AT rodriguezenriquezfernanda curcumincoumarinhybridanaloguesasmultitargetagentsinneurodegenerativedisorders
AT lagunareyes curcumincoumarinhybridanaloguesasmultitargetagentsinneurodegenerativedisorders
AT cutrinelena curcumincoumarinhybridanaloguesasmultitargetagentsinneurodegenerativedisorders
AT oterofrancisco curcumincoumarinhybridanaloguesasmultitargetagentsinneurodegenerativedisorders
AT uriarteeugenio curcumincoumarinhybridanaloguesasmultitargetagentsinneurodegenerativedisorders
AT vinadolores curcumincoumarinhybridanaloguesasmultitargetagentsinneurodegenerativedisorders